Akebia Therapeutics | AKBA - El Costo De Ventas





El Costo De Ventas Cambio Fecha
Acadia Pharmaceuticals USD 26.22M 4.58M 2025-12
Agios Pharmaceuticals USD 1.88M 199K 2025-12
Akebia Therapeutics USD 10.34M 441K 2025-12
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amgen USD 1.79B 128M 2025-12
Ardelyx USD 10.85M 6.87M 2025-12
Astellas Pharma JPY 149.13B 10.88B 2025-12
AstraZeneca USD 3.27B 471M 2025-12
Bayer EUR 4.5B 194M 2025-12
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Celltrion KRW 402.86B 14.24B 2025-09
Cspc Pharmaceutical CNY 2.28B 25.27M 2025-09
Deva Holding AS TRY 991.13M 182.81M 2023-09
Exelixis USD 26.48M 7.91M 2025-12
Fresenius Medical Care EUR 3.68B 38.37M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Ionis Pharmaceuticals USD 8M 5.66M 2025-12
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
J&J USD 7.97B 689M 2025-12
Kangmei Pharma CNY 1.11B 84.66M 2025-09
Karyopharm Therapeutics USD 37.43M 2.41M 2024-09
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Lexicon Pharmaceuticals USD 201K 191K 2025-12
Medical Developments International AUD 7.09M 4.91M 2025-12
Moderna USD 452M 245M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
Organigram Holdings CAD 56.93M 20.53M 2025-12
Pharma Mar EUR 3.77M 1.47M 2025-12
Prothena USD 28.94M 11.58M 2025-09
PTC Therapeutics USD 16.3M 7.02M 2025-12
Qiagen NV USD 217.43M 29.65M 2025-12
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 4.29B 421M 2025-12
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Sartorius EUR 450M 18.1M 2025-09
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Tilray USD 164.37M 8.41M 2025-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Zealand Pharma A/S 410K 5K 2025-06
Zz Pientze Pharmaceu CNY 1.34B 601.08M 2025-09